Among 26 evaluable patients with clear cell ovarian or endometrial cancer, the objective response rate with the regimen was ...

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

Immunotherapy treatments for cancer are having a moment. Some hospitals and health care systems call it a “miracle in the making” and a “game-changer.”It’s a treatment approach that ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

Immunotherapy is a form of cancer treatment that harnesses a person’s own immune system to target and fight the disease. Dostarlimab, developed by the pharmaceutical company GSK and sold under ...

Stallergenes Greer, Shionogi & Co., Ltd. ("Shionogi") and CEOLIA Pharma Co. Ltd ("CEOLIA") today announced the transition of promotional activities for Actair® in Japan. Actair® is Stallergenes ...

A form of immunotherapy gaining ground as a way to treat childhood food allergies has shown promise in treating another rising scourge of children and young adults: Type 1 diabetes.

Immunotherapy is a form of cancer treatment that harnesses a person’s own immune system to target and fight the disease. Dostarlimab, developed by the pharmaceutical company GSK and sold under ...